Business
Bacil Pharma Ltd Press Release Jun 29 2026
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Rajnikant Shah
About this update from Bacil Pharma Ltd
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Rajnikant ShahView Attachment